Secondary prevention and management of dyslipidaemia in patients with coronary artery disease on statin therapy in a tertiary academic centre in Johannesburg
Cardiovasc J Afr. 2025 Oct 9;36(3):323-330. doi: 10.5830/CVJA-2025-035. Epub 2025 Sep 30.ABSTRACTOptimal low-density lipoprotein cholesterol (LDL-C) control in patients with established atherosclerotic cardiovascular disease (ASCVD) is defined as LDL-C levels less than 1.4 mmol/L and a reduction of

